294 related articles for article (PubMed ID: 29040872)
1. Highly elevated plasma level of von Willebrand factor accelerates the formation of platelet thrombus under high shear stress in plasma with deficient ADAMTS13 activity.
Yagi H; Yamaguchi N; Shida Y; Sugimoto M; Tubaki K; Fujimura Y; Matsumoto M
Thromb Res; 2017 Nov; 159():91-95. PubMed ID: 29040872
[TBL] [Abstract][Full Text] [Related]
2. Plasma of patients with Upshaw-Schulman syndrome, a congenital deficiency of von Willebrand factor-cleaving protease activity, enhances the aggregation of normal platelets under high shear stress.
Yagi H; Konno M; Kinoshita S; Matsumoto M; Ishizashi H; Matsui T; Titani K; Fujimura Y
Br J Haematol; 2001 Dec; 115(4):991-7. PubMed ID: 11843838
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in thrombotic thrombocytopenic purpura.
Sadler JE; Moake JL; Miyata T; George JN
Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
[TBL] [Abstract][Full Text] [Related]
4. Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy.
Tersteeg C; de Maat S; De Meyer SF; Smeets MW; Barendrecht AD; Roest M; Pasterkamp G; Fijnheer R; Vanhoorelbeke K; de Groot PG; Maas C
Circulation; 2014 Mar; 129(12):1320-31. PubMed ID: 24449821
[TBL] [Abstract][Full Text] [Related]
5. Upshaw-Schulman syndrome revisited: a concept of congenital thrombotic thrombocytopenic purpura.
Kinoshita S; Yoshioka A; Park YD; Ishizashi H; Konno M; Funato M; Matsui T; Titani K; Yagi H; Matsumoto M; Fujimura Y
Int J Hematol; 2001 Jul; 74(1):101-8. PubMed ID: 11530798
[TBL] [Abstract][Full Text] [Related]
6. Upshaw-Schulman syndrome-associated ADAMTS13 variants possess proteolytic activity at the surface of endothelial cells and in simulated circulation.
Letzer A; Lehmann K; Mess C; König G; Obser T; Peine S; Schneppenheim S; Budde U; Schneider SW; Schneppenheim R; Brehm MA
PLoS One; 2020; 15(5):e0232637. PubMed ID: 32365113
[TBL] [Abstract][Full Text] [Related]
7. [ADAMTS13, von Willebrand factor specific cleaving protease].
Veyradier A; Coppo P
Med Sci (Paris); 2011 Dec; 27(12):1097-105. PubMed ID: 22192749
[TBL] [Abstract][Full Text] [Related]
8. [Genetic polymorphism of von Willebrand factor (VWF)-cleaving protease, ADAMTS13].
Kokame K
Brain Nerve; 2008 Nov; 60(11):1325-32. PubMed ID: 19069166
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of thrombotic thrombocytopenic purpura: ADAMTS13 deficiency and beyond.
Lian EC
Semin Thromb Hemost; 2005 Dec; 31(6):625-32. PubMed ID: 16388413
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis of ADAMTS13 dysfunction in thrombotic thrombocytopenic purpura.
Manea M; Karpman D
Pediatr Nephrol; 2009 Mar; 24(3):447-58. PubMed ID: 18807073
[TBL] [Abstract][Full Text] [Related]
11. Endothelial Cell-Derived von Willebrand Factor Is the Major Determinant That Mediates von Willebrand Factor-Dependent Acute Ischemic Stroke by Promoting Postischemic Thrombo-Inflammation.
Dhanesha N; Prakash P; Doddapattar P; Khanna I; Pollpeter MJ; Nayak MK; Staber JM; Chauhan AK
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1829-37. PubMed ID: 27444201
[TBL] [Abstract][Full Text] [Related]
12. ADAMTS13 unbound to larger von Willebrand factor multimers in cryosupernatant: implications for selection of plasma preparations for thrombotic thrombocytopenic purpura treatment.
Hori Y; Hayakawa M; Isonishi A; Soejima K; Matsumoto M; Fujimura Y
Transfusion; 2013 Dec; 53(12):3192-202. PubMed ID: 23560518
[TBL] [Abstract][Full Text] [Related]
13. Transfusion of Platelets Loaded With Recombinant ADAMTS13 (A Disintegrin and Metalloprotease With Thrombospondin Type 1 Repeats-13) Is Efficacious for Inhibiting Arterial Thrombosis Associated With Thrombotic Thrombocytopenic Purpura.
Abdelgawwad MS; Cao W; Zheng L; Kocher NK; Williams LA; Zheng XL
Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2731-2743. PubMed ID: 30354235
[TBL] [Abstract][Full Text] [Related]
14. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
Furlan M; Lämmle B
Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
[TBL] [Abstract][Full Text] [Related]
15. [Von Willebrand factor and ADAMTS13 balancing primary haemostasis].
Schneppenheim R; Budde U
Hamostaseologie; 2011 Nov; 31(4):275-80. PubMed ID: 21792464
[TBL] [Abstract][Full Text] [Related]
16. Size regulation of von Willebrand factor-mediated platelet thrombi by ADAMTS13 in flowing blood.
Donadelli R; Orje JN; Capoferri C; Remuzzi G; Ruggeri ZM
Blood; 2006 Mar; 107(5):1943-50. PubMed ID: 16293606
[TBL] [Abstract][Full Text] [Related]
17. Two newborn-onset patients of Upshaw-Schulman syndrome with distinct subsequent clinical courses.
Tanabe S; Yagi H; Kimura T; Isonishi A; Kato S; Yoshida Y; Hayakawa M; Matsumoto M; Ohtaki S; Takahashi Y; Fujimura Y
Int J Hematol; 2012 Dec; 96(6):789-97. PubMed ID: 23188471
[TBL] [Abstract][Full Text] [Related]
18. Novel monoclonal antibody-based enzyme immunoassay for determining plasma levels of ADAMTS13 activity.
Kato S; Matsumoto M; Matsuyama T; Isonishi A; Hiura H; Fujimura Y
Transfusion; 2006 Aug; 46(8):1444-52. PubMed ID: 16934083
[TBL] [Abstract][Full Text] [Related]
19. Thrombosis and von Willebrand Factor.
Shahidi M
Adv Exp Med Biol; 2017; 906():285-306. PubMed ID: 27628010
[TBL] [Abstract][Full Text] [Related]
20. [Thrombotic Thrombocytopenic Purpura --Pathophysiology and Assays of ADAMTS13 Activity].
Kato S; Fujimura Y
Rinsho Byori; 2015 Oct; 63(10):1228-36. PubMed ID: 26897861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]